|本期目录/Table of Contents|

[1]阮毅,于洋△,熊于勤,等.血液透析相关中心静脉闭塞性疾病诊治进展*[J].生物医学工程研究,2022,03:332-339.
 RUAN Yi,YU Yang,XIONG Yuqin,et al.Diagnosis and treatment of central venous occlusive diseases in patients on maintenance hemodialysis[J].Journal of Biomedical Engineering Research,2022,03:332-339.
点击复制

血液透析相关中心静脉闭塞性疾病诊治进展*(PDF)

《生物医学工程研究》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2022年03期
页码:
332-339
栏目:
出版日期:
2022-09-25

文章信息/Info

Title:
Diagnosis and treatment of central venous occlusive diseases in patients on maintenance hemodialysis
文章编号:
1672-6278 (2022)03-0332-08
作者:
阮毅1于洋12△熊于勤3付平1陈宇4
1.四川大学华西医院肾脏内科/肾脏病研究所,成都 610041;2.四川大学华西医院介入诊疗中心,成都 610041;3.四川大学华西公共卫生学院/华西第四医院,成都 610041;4.四川大学建筑与环境学院力学科学与工程系,成都 610065
Author(s):
RUAN Yi1 YU Yang12 XIONG Yuqin3 FU Ping1 CHEN Yu4
1.Department of Nephrology,West China Hospital, Sichuan University, Chengdu 610041, China;2.Center of Interventional Therapy,West China Hospital, Sichuan University, Chengdu 610041;3.West China School of Public Health and West China Fourth Hospital,Sichuan University,Chengdu 610041; 4.College of Architecture and Environment,Sichuan University,Chengdu 610065
关键词:
维持性血液透析终末期肾脏病血管通路中心静脉狭窄危险因素临床诊断介入治疗放射性
Keywords:
Maintenance hemodialysisEnd-stage renal diseaseVascular accessCentral venous stenosisRisk factorsDiagnosisInterventional therapyRadioactiuity
分类号:
R318;R45; R543; R816
DOI:
-
文献标识码:
A
摘要:
中心静脉闭塞性疾病(central venous occlusive disease, CVOD)是维持性血透患者常见且严重的血管通路并发症之一。中心静脉透析导管留置时间、位置、管径及透析内瘘的高流量是血透相关CVOD的主要危险因素。经皮球囊扩张血管成形术(percutaneous transluminal angioplasty,PTA)和经皮支架植入血管成形术(percutaneous transluminal angioplasty with stent placement,PTS)是症状性CVOD的主要治疗手段。CVOD据不同病因、病变严重程度和解剖位置,其治疗难度与远期预后有所不同,需考虑不同的治疗策略。目前关于CVOD的临床研究局限于小样本回顾性观察研究,基础研究较匮乏,CVOD诊治新技术与新器械需在未来的研究中进一步探索和验证。
Abstract:
Central venous occlusive disease (CVOD) is a common and intractable complication which can directly lead to dysfunction of vascular access in patients on maintenance hemodialysis. The indwelling duration, location and diameter of central venous dialysis catheter, and dialysis fistula with high-flow are the mainly known risk factors for CVOD. Percutaneous transluminal angioplasty (PTA) and percutaneous transluminal angioplasty with stent placement (PTS) are recommended as the first-line treatment strategy for symptomatic CVOD.CVOD shows varied difficulties in treatment and different long-term outcomes because of the different etiologies, severity of the lesion and anatomical locations of the lesion, hencetargeted interventional strategies should be considered.At present, clinical studies on CVOD are limited to retrospective observational reports with small samples,and experimental studies are scarce. New techniques and instruments for the diagnosis and treatment of CVOD need to be further explored and verified in future studies.

参考文献/References

备注/Memo

备注/Memo:
(收稿日期:2022-06-10)四川省科技重点研发计划项目(21ZDYF1847)。△通信作者Email:yuyang@wchscu.cn
更新日期/Last Update: 2022-11-08